Showing results (2191-2200 of 2,282) with videos related to

Sort By:
Pageof 229
Retrovirology|November 11, 2017
The HIV-1 integrase-LEDGF allosteric inhibitor MUT-A: resistance profile, impairment of virus maturation and infectivity but without influence on RNA packaging or virus immunoreactivityCéline Amadori, Yme Ubeles van der Velden, Damien Bonnard, et al.
Cancer Discovery|October 20, 2022
Osimertinib + Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor-Mutated, MET-Amplified Non-Small Cell Lung Cancer: TATTONRyan J Hartmaier, Aleksandra A Markovets, Myung Ju Ahn, et al.
European Journal of Applied Physiology|April 2, 2025
Multidirectional effect of low-intensity neuromuscular electrical stimulation on gene expression and phenotype in thigh and calf muscles after one week of disuseAnna A Borzykh, Roman Y Zhedyaev, Ivan I Ponomarev, et al.
Investigational New Drugs|May 9, 2019
A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesotheliomaEmilie M J van Brummelen, Evgeny Levchenko, Manuel Dómine, et al.
The Review of Scientific Instruments|June 3, 2010
A cryogenic electrostatic trap for long-time storage of keV ion beamsM Lange, M Froese, S Menk, et al.
Lancet (London, England)|January 28, 2017
First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 studyJean-Charles Soria, Daniel S W Tan, Rita Chiari, et al.
Science (New York, N.Y.)|July 20, 2019
Quantum-state-selective electron recombination studies suggest enhanced abundance of primordial HeH.Oldřich Novotný, Patrick Wilhelm, Daniel Paul, et al.
Kardiologiia|July 14, 2022
[Correlations between vessel stiffness and biomarkers of senescent cell in elderly patients]A G Sorokina, A Yu Efimenko, O A Grigorieva, et al.
Lancet (London, England)|June 17, 2014
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trialEdward B Garon, Tudor-Eliade Ciuleanu, Oscar Arrieta, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 10, 2019
Efficacy and Safety of Ceritinib (450 mg/d or 600 mg/d) With Food Versus 750-mg/d Fasted in Patients With ALK Receptor Tyrosine Kinase (ALK)-Positive NSCLC: Primary Efficacy Results From the ASCEND-8 StudyByoung Chul Cho, Radka Obermannova, Alessandra Bearz, et al.
Pageof 229